RxDoctor Payments Data

Bethany Heffelfinger, APRN

Family · Mansfield, OHNPI 1376122531

Payments from drug & device makers

$982in general payments, 2019–2025

Across 52 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$220
  • Pfizer$204
  • Amgen$139
  • Boehringer Ingelheim$128
  • Biosense Webster, Inc.$81
  • E.r. Squibb & Sons, L.L.C.$52
  • plus $159 from 5 others

What the payments were for

  • Food & beverage$982100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$982 in reported general payments places this provider in the 70th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$24,574
Medicare patients
239
Services billed
629

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban693$703,562
XareltoRivaroxaban119$120,052
EntrestoSacubitril/Valsartan103$107,625
Repatha SureclickEvolocumab76$67,778
BrilintaTicagrelor49$30,203
JardianceEmpagliflozin14$19,592
FarxigaDapagliflozin Propanediol22$18,340
VascepaIcosapent Ethyl27$14,193
Metoprolol Succinate692$7,016
Atorvastatin Calcium534$5,344
Diltiazem 24hr Er (Cd)Diltiazem Hcl188$4,776
ClopidogrelClopidogrel Bisulfate395$4,505
Ezetimibe155$4,159
Ranolazine ErRanolazine49$2,849
Dabigatran EtexilateDabigatran Etexilate Mesylate14$2,588

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$204$703,562693 claims
Johnson & JohnsonXarelto$46$120,052119 claims
NovartisEntresto$220$107,625103 claims
AstraZenecaBrilinta, Farxiga$29$48,54371 claims
Boehringer IngelheimJardiance$128$19,59214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,812 family providers in Ohio.

Other family in Mansfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →